D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Slides:

Advertisements

Similar presentations

Kamyar Kalantar-Zadeh Kidney International

Advertisements

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Beta blockers in the management of chronic kidney disease

Iron indices: What do they really mean?

A. Besarab Kidney International Volume 69, Pages S13-S18 (May 2006)

Iron status and iron supplementation in peritoneal dialysis patients

Anemia management in chronic kidney disease

American Journal of Kidney Diseases

Impact of new dialysis solutions on peritonitis rates

Volume 64, Pages S72-S77 (November 2003)

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target Szu-Chun Hung, Der-Cherng Tarng Kidney International

Progression of renal failure and hypertensive nephrosclerosis

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Yasuhiro Hamada, Masafumi Fukagawa Kidney International

Overcoming barriers that inhibit proper treatment of anemia

Volume 71, Issue 8, Pages (April 2007)

Kamyar Kalantar-Zadeh Kidney International

Volume 70, Pages S21-S25 (December 2006)

Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: A simple assessment of symptom burden S.N. Davison, G.S.

Anemia as a risk factor for chronic kidney disease

A new era in phosphate binder therapy: What are the options?

Proinflammatory effects of iron sucrose in chronic kidney disease

Volume 70, Issue 11, Pages (December 2006)

Joseph W. Eschbach, John W. Adamson Kidney International

Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover.

Volume 77, Pages S8-S11 (March 2010)

Volume 73, Pages S5-S17 (April 2008)

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Blood pressure targets in hemodialysis patients

Fructose intake as a risk factor for kidney stone disease

Recent experience with high-dose intravenous iron administration

The third World Kidney Day: Looking back and thinking forward

Volume 64, Pages S72-S77 (November 2003)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

The value of ferric citrate, an iron-containing phosphate binder, might be different between Japan and the United States Keitaro Yokoyama, Yukio Maruyama,

Volume 79, Issue 3, Pages (February 2011)

Microbiology and outcomes of peritonitis in North America

AGEs in foods: Do they play a role in uremia?

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Counteracting progression of renal disease: A look into the future

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 73, Pages S72-S75 (April 2008)

Volume 71, Issue 4, Pages (February 2007)

Fibroblast growth factor 23: the making of a hormone

Volume 55, Issue 5, Pages (May 1999)

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Phosphate binders on iron basis: A new perspective?

Organ transplantation goes to the movies

Volume 70, Pages S84-S90 (November 2006)

Volume 72, Issue 2, Pages (July 2007)

Is it the low-protein diet or simply the salt restriction?

Volume 69, Issue 10, Pages (May 2006)

Charles A. Herzog Kidney International

Urinalysis in Western culture: A brief history

Volume 70, Issue 3, Pages (August 2006)

Volume 71, Issue 9, Pages (May 2007)

Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate S. Aime, C. Canavese, P. Stratta Kidney International

Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation A.K. Singh, D.W. Coyne,

Volume 70, Issue 5, Pages (September 2006)

Strategies for iron supplementation: Oral versus intravenous

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 69, Issue 8, Pages (April 2006)

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Presentation transcript:

Challenging the boundaries of anemia management: a balanced approach to i.v. iron and EPO therapy D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006) DOI: 10.1038/sj.ki.5000402 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 EPO dosing in patients with low serum ferritin (<100 ng/ml) and low iron saturation (<20%) values for the first 6 months of 2003. Patients who received i.v. iron had a better response to EPO therapy compared with patients who did not receive i.v. iron.2 Kidney International 2006 69, S1-S3DOI: (10.1038/sj.ki.5000402) Copyright © 2006 International Society of Nephrology Terms and Conditions